Community/Retail

A recent survey concluded that strategies to increase workplace immunization, such as requiring vaccination or promoting free onsite vaccines, lead to increased vaccination rates.

The Drug Enforcement Administration is placing Epidiolex in Schedule V, the least restrictive of the Controlled Substances Act

Two lots of Robaxin® (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack are being voluntarily recalled by Endo Pharmaceuticals Inc., due to incorrent dosing information on the label.

Metabolic syndrome involves multiple disease states including hypertension, hyperlipidemia, and possibly diabetes.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

Celebrating the expanded role of pharmacists across the nation, McKesson Corporation has kicked off an entire month of celebrations for American Pharmacists Month.

Officials with the FDA have approved Admais’ 0.15mg Symjepi for the emergency treatment of allergic reactions, including anaphylaxis, in children.

A global survey found that 2 of 3 individuals with type 2 diabetes had experienced a cardiovascular disease (CVD) event or had CVD risk factors.

The FDA has approved amikacin liposome inhalation suspension (Arikayce, Insmed), for the treatment of lung disease caused by a group of bacteria in a limited population of patients with the disease who do not respond to conventional treatment.

The FDA has expanded the indication of the antiepileptic drug perampanel (FYCOMPA®, Eisai) CIII for monotherapy and adjunctive use in pediatric patients aged 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures.

Get involved this October and show your appreciation for the work pharmacists do.

Dacomitinib tablets (Vizimpro, Pfizer) received FDA approval for the first-line treatment of patients with metastatic non-small cell lung cancer.

The FDA has approved Eli Lilly’s preventive migraine treatment galcanezumab-gnlm (Emgality).

Pregnant women take herbal and natural products (HNPs) as alternatives to prescription medications, but, HNPs have active ingredients and drug interactions that can potentially cause harm to both the mother and her baby.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A Mississippi nurse practioner and former family clinic owner was sentenced to 42 months in prison and ordered to pay more than $1 million in restitution for her role in a health care benefits fraud scheme.

A generic version of Cialis® (tadalafil, Eli Lilly) tablets (2.5 mg, 5 mg, 10 mg, 20 mg) for the United States market has been annouced by Teva Pharmaceuticals

National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses.

A pair of bipartisan bills that would lift ‘gag clauses’ prohibiting lower prescription drug price information to be shared with customers have been passed by the House of Representatives and the Senate.

Unprecedented in scale, the AMR Challenge charges pharmaceutical and health insurance companies, food animal producers and purchasers, medical professionals, government health officials, and other industry leaders from around the world to work together to address antibiotic resistance.

Inconsistency of insurance policy coverage, unaffordability, and difficulty accessing vaccine providers were found to be key barriers for adult immunization in a recent study by UCLA Center for Health Policy researchers.

The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program.

The CLL/SLL indication is a standard approval and the follicular lymphoma indication is an accelerated approval contingent on the results of a confirmatory trial

World Pharmacists Day is being celebrated Tuesday around the globe.

A pharmacy owner facing an indictment charging her with submitting millions of dollars in fraudulent claims to Medicare and Medicaid is expected to be arraigned today in federal court in Brooklyn, New York.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

A federal appropriations bill will not include bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.